These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 19036916)

  • 1. Modelling the past, current and future HCV burden in France: detailed analysis and perspectives.
    Deuffic-Burban S; Mathurin P; Valleron AJ
    Stat Methods Med Res; 2009 Jun; 18(3):233-52. PubMed ID: 19036916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality.
    Lehman EM; Wilson ML
    J Viral Hepat; 2009 Sep; 16(9):650-8. PubMed ID: 19413698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the hepatitis C virus epidemic in France.
    Deuffic S; Buffat L; Poynard T; Valleron AJ
    Hepatology; 1999 May; 29(5):1596-601. PubMed ID: 10216148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infections.
    Deuffic-Burban S; Mohamed MK; Larouze B; Carrat F; Valleron AJ
    J Hepatol; 2006 Mar; 44(3):455-61. PubMed ID: 16310281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global burden of disease (GBD) for hepatitis C.
    Global Burden Of Hepatitis C Working Group
    J Clin Pharmacol; 2004 Jan; 44(1):20-9. PubMed ID: 14681338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling and calibration of the hepatitis C epidemic in Australia.
    Razali K; Amin J; Dore GJ; Law MG; HCV Projections Working Group
    Stat Methods Med Res; 2009 Jun; 18(3):253-70. PubMed ID: 19036911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States.
    Deuffic-Burban S; Poynard T; Sulkowski MS; Wong JB
    J Viral Hepat; 2007 Feb; 14(2):107-15. PubMed ID: 17244250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatitis C in Poland in 2006].
    Bobel D; Rosińska M
    Przegl Epidemiol; 2008; 62(2):325-32. PubMed ID: 18807475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of viral eradication on mortality related to hepatitis C: a modeling approach in France.
    Deuffic-Burban S; Deltenre P; Louvet A; Canva V; Dharancy S; Hollebecque A; Boitard J; Henrion J; Yazdanpanah Y; Mathurin P
    J Hepatol; 2008 Aug; 49(2):175-83. PubMed ID: 18538441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatitis C in Poland in 2007].
    Laskus I; Rosińska M
    Przegl Epidemiol; 2009; 63(2):251-4. PubMed ID: 19799255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment and proposal of a new combination of screening criteria for hepatitis C in France.
    King LA; Le Strat Y; Meffre C; Delarocque-Astagneau E; Desenclos JC
    Eur J Public Health; 2009 Oct; 19(5):527-33. PubMed ID: 19667051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents.
    Grebely J; Raffa JD; Lai C; Krajden M; Kerr T; Fischer B; Tyndall MW
    J Viral Hepat; 2009 May; 16(5):352-8. PubMed ID: 19226330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of intrafamilial transmission of hepatitis C virus and low risk for sexual transmission in rural central Africa indicate a cohort effect.
    Ndong-Atome GR; Njouom R; Padilla C; Bisvigou U; Makuwa M; Kazanji M
    J Clin Virol; 2009 Aug; 45(4):349-53. PubMed ID: 19473878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Investigating genotype of HCV distribution among residents in a "blood donation" village in Hebei Province].
    Huang CH; Zhou JK; Liu L; Jiang RM; Cao YQ; Mu ZY; Zhang Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Feb; 23(1):8-10. PubMed ID: 19799004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre-model for end-stage liver disease eras and the independent impact of hepatitis C virus.
    Thuluvath PJ; Maheshwari A; Thuluvath NP; Nguyen GC; Segev DL
    Liver Transpl; 2009 Jul; 15(7):754-62. PubMed ID: 19562709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virological and biochemical features in elderly HCV patients with hepatocellular carcinoma: amino acid substitutions in HCV core region as predictor of mortality after first treatment.
    Ogura S; Akuta N; Hirakawa M; Kawamura Y; Yatsuji H; Sezaki H; Hosaka T; Kobayashi M; Suzuki F; Suzuki Y; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
    Intervirology; 2009; 52(4):179-88. PubMed ID: 19546575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and geographic distribution of Hepatitis C Virus genotypes in Indian patient cohort.
    Narahari S; Juwle A; Basak S; Saranath D
    Infect Genet Evol; 2009 Jul; 9(4):643-5. PubMed ID: 19460332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing the public health burden of chronic hepatitis C and HIV infection in France.
    Deuffic-Burban S; Wong JB; Valleron AJ; Costagliola D; Delfraissy JF; Poynard T
    J Hepatol; 2004 Feb; 40(2):319-26. PubMed ID: 14739105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B and hepatitis C in 2009.
    Marcellin P
    Liver Int; 2009 Jan; 29 Suppl 1():1-8. PubMed ID: 19207959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses.
    Wang CS; Yao WJ; Chang TT; Wang ST; Chou P
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2054-60. PubMed ID: 19549812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.